Onyx Biotec Committee of Independent Directors Recommends Open Offer
Onyx Biotec Ltd 路 Others (Uncategorized) 路 08 Oct 2026, 10:08 pm
Onyx Biotec Committee of Independent Directors Recommends Open Offer Onyx Biotec Limited announced that its Committee of Independent Directors (IDC) published its recommendations on 8th Oct'26 regarding the open offer by Kunal Bhardwaj, Gautam Bhardwaj, Kanhaiya Bhardwaj, and Kapil Bhardwaj. The acquirers offered to acquire up to 47,14,372 equity shares (26.00% of voting share capital) of face value Rs. 10 each. Based on the valuation report by independent valuer Brijesh Kumar confirming a fair value of Rs. 34.51 per share, the IDC recommended the offer price of Rs. 36.50 per share as fair and reasonable.
Original exchange filing (PDF)
More announcements from Onyx Biotec Ltd
- Onyx Biotec Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 14 Nov 2026
- Onyx Biotec Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of corrigendum to the letter of offer for the attention to the public shareholders of the Onyx Biotec Limited. 路 12 Nov 2026
- Onyx Biotec Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of offer opening public announcement cum corrigendum to the detailed public statement to the public shareholders of the聽Onyx Biotec Limited (Target Company). 路 14 Oct 2026
- Onyx Biotec Limited has informed regarding Submission of the Non-Applicability of the provisions relating to Corporate Governance as specified in the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 路 14 Oct 2026
- Onyx Biotec Limited has Submitted to the Exchange the outcome of the meeting of the committee of the Independent Directors held today i.e. October 07, 2026 to give their recomendation in the Open Offer of Onyx Biotec Limited in compliance with Regulation 26(7) of the SEBI (SAST) Regulations, 2011and subsequent Amendments thereto. 路 08 Oct 2026
